Home >Newsletters >August 1997
 
ASA NEWSLETTER
 
 
August 1997
Volume 61
Number 8
 

Measuring Pain Management Outcome:
The Political Point of View

David C. Mackey, M.D.
Committee on Pain Management



There is little doubt that anesthesiologists have historically provided the principal leadership in the development of the practice of pain medicine. Our specialty has played a major role in the clinical care of pain patients, in research and in the development of pain specialty certification. However, studies continue to document the persisting prevalence of inadequate pain management,1-3 and prominent physicians note the need for medical regulatory reforms to address this problem.4-5 In addition, new issues such as practice guidelines and standards, cost efficacy and outcome analysis are playing increasingly prominent roles in this era of managed care, medical consumerism, malpractice liability and accelerating governmental regulation.

If the specialty of anesthesiology wishes to maintain its influence in the field of pain medicine, it will need to acknowledge these issues and move aggressively to address them. Such leadership will be of great value to individual physicians, governmental regulators, third-party payers and, most importantly, to patients with acute or chronic pain. If we cannot justify the societal value of pain management, it will wither as a specialty since there will be no one willing to pay for it. If we are unwilling or unable to assume leadership in the further development of this specialty area, we must be willing to accept the inevitable consequences of surrendering physician control to nonphysician influences.

The increasing importance of nonphysician influences in medicine is not necessarily bad. Indeed, one can look to the state of Florida as an example of the utility of governmental processes in improving the care of the pain patient. The Florida Agency for Health Care Administration (AHCA) and the Florida Department of Health have taken aggressive stances in health care regulation relating to pain management through enactment of the Florida Intractable Pain Statute, creation of the Florida Pain Management Commission and development of a specialized review process for pain management disciplinary cases referred to the Florida Board of Medicine. The 1995 enactment of the Florida Intractable Pain Statute improves patient care by reassuring physicians that they can appropriately prescribe controlled substances to patients with acute or chronic intractable pain without fear of unreasonable licensure review and discipline [Table 1].6

The Florida Pain Management Commission is another mechanism through which the state is attempting to improve the health care of its citizens. Organized in 1995, it consists of 20 members with representatives from AHCA, the Florida Boards of Medicine, Osteopathic Medicine, Nursing, Pharmacy, and Chiropractic Medicine, and the U.S. Drug Enforcement Administration. After a series of public forums, it sent a report to the state legislature including the following recommendations:

  1. Continue the funding of the Commission as a voluntary advisory and educational resource to Florida legislators and regulatory personnel, health care professionals and the general public.
  2. Recognize chronic pain as a legitimate condition with appropriate coding for reimbursement of services.
  3. Provide greater flexibility to physicians regarding prescriptions for chronic pain patients.
  4. Provide centralized statewide registry of pain management centers, including description of services and basic fee structure.
  5. Promote pain management educational programs for health care providers and pain patients.
  6. Provide a clearinghouse for pain management information, including patient education materials, professional training programs, pain management guidelines and research­based outcome studies.
  7. Encourage pain management research, development of a statewide outcomes database, and technology to access national pain management­related resources. The Florida Pain Management Commission is currently working on legislation to accomplish many of the above goals.

Lastly, the problem of the Florida Board of Medicine's review of physician disciplinary cases involving pain management has been specifically addressed. Whereas in the past such cases might have been reviewed by one or more physicians with little or no specific experience or expertise in pain management, now all such cases are reviewed by members of a panel of pain management specialists. This proactive stance by the Florida Board of Medicine will help assure practitioners involved in the medical disciplinary process that cases involving pain management will be reviewed fairly and accurately.

Recent events in the state of Florida illustrate the potential and real impact of governmental regulatory, disciplinary and legislative forces upon the practice of pain management. In addition, patients (consumers), hospitals, managed care organizations and third-party payers will increasingly look to government agencies for help in addressing issues such as cost, quality and professional qualifications. Pain management specialists must become involved in these processes in order to prove the value of their work and to guide its regulation. Such activity is absolutely essential for the welfare of their patients and for the survival of their profession.

 

References:
  1. Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med. 1993; 119:121-126.
  2. Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994; 330:592-596.
  3. Hill CS Jr. Government regulatory influences on opioid prescribing and their impact on the treatment of pain of nonmalignant origin. J Pain Symptom Manage. 1996; 11:287-298.
  4. Hill CS Jr. When will adequate pain treatment be the norm? JAMA. 1995; 274:1881-1882.
  5. Foley KM. Pain relief into practice: Rhetoric without reform. J Clin Oncol. 1995; 13:2149-2151.
  6. Mackey DC, Grossman AR. Narcotic prescription for pain management in Florida: The physician and the law. J Florida Med Assoc. 1996; 83:673-674.


Table 1

Florida Medical Practice Act §458.326
Intractable pain; authorized treatment:

  1. For the purposes of this section, the term "intractable pain" means pain for which, in the generally accepted course of medical practice, the cause cannot be removed and otherwise treated.
  2. Intractable pain must be diagnosed by a physician licensed under this chapter and qualified by experience to render such diagnosis.
  3. Notwithstanding any other provision of law, a physician may prescribe or administer any controlled substance under Schedules II­V, as provided for in S893.03, to a person for the treatment of intractable pain, provided the physician does so in accordance with that level of care, skill and treatment recognized by a reasonably prudent physician under similar conditions and circumstances.
  4. Nothing in this section shall be construed to condone, authorize or approve mercy killing or euthanasia, and no treatment authorized by this section may be used for such purpose.


David C. Mackey, M.D., is a Consultant in Anesthesiology and Medicine at the Mayo Clinic Jacksonville, Jacksonville, Florida. He is a member of the Florida Pain Commission and the Medical Advisory Committee of the Florida Agency for Health Care Administration.
E-mail the author.

 


return to top


 


FEATURES

Pain and Its Relief

ARTICLES


DEPARTMENTS


The views expressed herein are those of the authors and do not necessarily represent or reflect the views, policies or actions of the American Society of Anesthesiologists.

NL Archives

Information for Authors